New England Research & Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-16,616
| Closed | -$1.07M | – | 186 |
|
|
2018
Q4 | $1.07M | Sell |
16,616
-610
| -4% | -$39.1K | 0.84% | 42 |
|
|
2018
Q3 | $1.54M | Sell |
17,226
-1,450
| -8% | -$130K | 1% | 31 |
|
|
2018
Q2 | $1.48M | Buy |
18,676
+900
| +5% | +$71.5K | 0.98% | 30 |
|
|
2018
Q1 | $1.59M | Buy |
17,776
+5,150
| +41% | +$459K | 1.06% | 24 |
|
|
2017
Q4 | $1.32M | Buy |
12,626
+1,792
| +17% | +$187K | 0.94% | 38 |
|
|
2017
Q3 | $1.58M | Sell |
10,834
-350
| -3% | -$51K | 1.16% | 22 |
|
|
2017
Q2 | $1.45M | Buy |
11,184
+1,234
| +12% | +$160K | 1.07% | 25 |
|
|
2017
Q1 | $1.24M | Sell |
9,950
-1,325
| -12% | -$165K | 0.95% | 29 |
|
|
2016
Q4 | $1.31M | Sell |
11,275
-3,480
| -24% | -$403K | 1.02% | 22 |
|
|
2016
Q3 | $1.54M | Sell |
14,755
-3,000
| -17% | -$314K | 1.29% | 14 |
|
|
2016
Q2 | $1.75M | Sell |
17,755
-275
| -2% | -$27.1K | 1.51% | 9 |
|
|
2016
Q1 | $1.81M | Buy |
18,030
+2,300
| +15% | +$230K | 1.53% | 10 |
|
|
2015
Q4 | $1.88M | Sell |
15,730
-470
| -3% | -$56.3K | 1.63% | 9 |
|
|
2015
Q3 | $1.75M | Buy |
16,200
+135
| +0.8% | +$14.6K | 1.67% | 10 |
|
|
2015
Q2 | $1.86M | Buy |
16,065
+3,615
| +29% | +$418K | 1.52% | 8 |
|
|
2015
Q1 | $1.44M | Buy |
12,450
+1,325
| +12% | +$153K | 1.23% | 14 |
|
|
2014
Q4 | $1.24M | Sell |
11,125
-2,305
| -17% | -$258K | 1.07% | 15 |
|
|
2014
Q3 | $1.27M | Sell |
13,430
-50
| -0.4% | -$4.74K | 1.11% | 15 |
|
|
2014
Q2 | $1.16M | Sell |
13,480
-2,150
| -14% | -$185K | 1.04% | 24 |
|
|
2014
Q1 | $1.09M | Sell |
15,630
-1,170
| -7% | -$81.7K | 1% | 29 |
|
|
2013
Q4 | $1.42M | Buy |
+16,800
| New | +$1.42M | 1.37% | 13 |
|